Disruption of brain-blood barrier might influence progression of Alzheimer's

by VIB (the Flanders Institute for Biotechnology)Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.More and more data from preclinical and clinical st

Updated on: February 26,2024

Disruption of brain-blood barrier might influence progression of Alzheimer's

by VIB (the Flanders Institute for Biotechnology)Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.More and more data from preclinical and clinical st

Updated on:February 26,2024

Brain changes: Examining the lingering effects of COVID-19

by Society for NeuroscienceCredit: Pixabay/CC0 Public DomainMore profoundly than previously believed, the virus that causes COVID-19, SARS-CoV-2, can impact the brain for months after infection.

Updated on: February 18,2024

Brain changes: Examining the lingering effects of COVID-19

by Society for NeuroscienceCredit: Pixabay/CC0 Public DomainMore profoundly than previously believed, the virus that causes COVID-19, SARS-CoV-2, can impact the brain for months after infection.

Updated on:February 18,2024

New treatments for Alzheimer's and stroke revealed in several new studies

by American Physiological SocietyCredit: Pixabay/CC0 Public DomainThe results of three new studies indicate there could be new treatments for Alzheimer's and stroke. One study reveals a possi

Updated on: June 18,2024

New treatments for Alzheimer's and stroke revealed in several new studies

by American Physiological SocietyCredit: Pixabay/CC0 Public DomainThe results of three new studies indicate there could be new treatments for Alzheimer's and stroke. One study reveals a possi

Updated on:June 18,2024

Cancer chemotherapy drug reverses Alzheimer's symptoms in mice

by University of British ColumbiaCredit: Pixabay/CC0 Public DomainA drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer's d

Updated on: April 25,2024

Cancer chemotherapy drug reverses Alzheimer's symptoms in mice

by University of British ColumbiaCredit: Pixabay/CC0 Public DomainA drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer's d

Updated on:April 25,2024

Dementia and self-harm: Why it's crucial to support patients in first year after diagnosis

by Lachlan Gilbert,University of New South WalesCredit: AI-generated imagePeople diagnosed with dementia are more likely to self-harm within the first six to 12 months after initial diagnosis, h

Updated on: May 08,2024

Dementia and self-harm: Why it's crucial to support patients in first year after diagnosis

by Lachlan Gilbert,University of New South WalesCredit: AI-generated imagePeople diagnosed with dementia are more likely to self-harm within the first six to 12 months after initial diagnosis, h

Updated on:May 08,2024

Machine learning can predict rate of memory change

by Alzheimer's Research UKIn new research published today, researchers have created a machine learning algorithm that is able to form two distinct groups of people who have early memory probl

Updated on: March 07,2024

Machine learning can predict rate of memory change

by Alzheimer's Research UKIn new research published today, researchers have created a machine learning algorithm that is able to form two distinct groups of people who have early memory probl

Updated on:March 07,2024

Most with intractable Meniere disease experience symptom relief

by Elana GotkineMost patients with intractable Meniere disease (MD) experience symptom relief over time, according to a study published online Oct. 23 inFrontiers in Neurology.F.R. Gerritsen, fr

Updated on: December 23,2024

Most with intractable Meniere disease experience symptom relief

by Elana GotkineMost patients with intractable Meniere disease (MD) experience symptom relief over time, according to a study published online Oct. 23 inFrontiers in Neurology.F.R. Gerritsen, fr

Updated on:December 23,2024

Hallucinations from flickering lights: What happens in our brain?

by Netherlands Institute for Neuroscience - KNAWCredit:Current Biology(2024). DOI: 10.1016/j.cub.2024.07.091A new study from the Netherlands Institute for Neuroscience shows how flickering

Updated on: September 23,2024

Hallucinations from flickering lights: What happens in our brain?

by Netherlands Institute for Neuroscience - KNAWCredit:Current Biology(2024). DOI: 10.1016/j.cub.2024.07.091A new study from the Netherlands Institute for Neuroscience shows how flickering

Updated on:September 23,2024

Can the healthy brain offer clues to curing Alzheimer's?

by The ConversationImage of brain with regions of the medial temporal lobe colour-coded"Have you cured Alzheimer's disease yet?"This is a common question people ask when they discov

Updated on: June 24,2024

Can the healthy brain offer clues to curing Alzheimer's?

by The ConversationImage of brain with regions of the medial temporal lobe colour-coded"Have you cured Alzheimer's disease yet?"This is a common question people ask when they discov

Updated on:June 24,2024

Biogen cuts the price tag on its Alzheimer's drug in half

by Tom MurphyThe Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Biogen is slashing the price of its Alzheimer's treatment months after the drug debuted to widespread critic

Updated on: April 25,2024

Biogen cuts the price tag on its Alzheimer's drug in half

by Tom MurphyThe Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Biogen is slashing the price of its Alzheimer's treatment months after the drug debuted to widespread critic

Updated on:April 25,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on: April 16,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on:April 16,2024

First 'gene silencing' drug for Alzheimer's disease shows promise

by University College LondonEffect of MAPTRxon CSF concentrations of p-tau protein and tau/Aβ42. a, The mean percentage change from baseline in p-tau over time according to dose group. b, T

Updated on: March 30,2024

First 'gene silencing' drug for Alzheimer's disease shows promise

by University College LondonEffect of MAPTRxon CSF concentrations of p-tau protein and tau/Aβ42. a, The mean percentage change from baseline in p-tau over time according to dose group. b, T

Updated on:March 30,2024